
Mithramycin A
CAS No. 18378-89-7
Mithramycin A( Plicamycin | PA 144 | NSC 24559 )
Catalog No. M12838 CAS No. 18378-89-7
A tricyclic pentaglycosidic, antineoplastic antibiotic from Streptomyces strains that inhibits RNA and protein synthesis by adhering to DNA.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 385 | In Stock |
![]() ![]() |
10MG | 575 | In Stock |
![]() ![]() |
25MG | 888 | In Stock |
![]() ![]() |
100MG | Get Quote | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameMithramycin A
-
NoteResearch use only, not for human use.
-
Brief DescriptionA tricyclic pentaglycosidic, antineoplastic antibiotic from Streptomyces strains that inhibits RNA and protein synthesis by adhering to DNA.
-
DescriptionA tricyclic pentaglycosidic, antineoplastic antibiotic from Streptomyces strains that inhibits RNA and protein synthesis by adhering to DNA; binds to the minor groove of DNA at GC-rich sites, induces cancer cell apoptosis and metastasis.
-
In Vitro——
-
In Vivo——
-
SynonymsPlicamycin | PA 144 | NSC 24559
-
PathwayCell Cycle/DNA Damage
-
TargetDNA/RNA Synthesis
-
RecptorDNA/RNA Synthesis
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number18378-89-7
-
Formula Weight1085
-
Molecular FormulaC52H76O24
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 100 mg/mL (92.15 mM)
-
SMILESO=C1[C@@H](O[C@H]2C[C@@H](O[C@H]3C[C@@H](O[C@H]4C[C@](C)(O)[C@H](O)[C@@H](C)O4)[C@H](O)[C@@H](C)O3)[C@H](O)[C@@H](C)O2)[C@H]([C@H](OC)C([C@@H](O)[C@H](O)C)=O)CC5=C1C(O)=C6C(O)=C(C)C(O[C@H]7C[C@@H](O[C@H]8C[C@@H](O)[C@H](O)[C@@H](C)O8)[C@H](O)[C@@H](C)O7)=CC6=C5
-
Chemical Name(2S,3S)-3-((1S,3S,4R)-3,4-dihydroxy-1-methoxy-2-oxopentyl)-2-(((2S,4R,5R,6R)-4-(((2S,4R,5S,6R)-4-(((2S,4S,5R,6R)-4,5-dihydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-5-hydroxy-6-methyltetrahydro-2H-pyran-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Boro A, et al. Int J Cancer. 2012 Nov 1;131(9):2153-64.
2. Lee TJ, et al. Mol Cancer Ther. 2006 Nov;5(11):2737-46.
3. Majee S, et al. Biochem Pharmacol. 1999 May 1;57(9):981-7.
molnova catalog



related products
-
TH-287
A potent and selective inhibitor of MTH1 protein with IC50 of 0.8 nM.
-
Helicid
Helicid is a medicine available in a number of countries worldwide.
-
Fialuridine
Fialuridine is a DNA-directed DNA polymerase inhibitor potentially for the treatment of HBV infection with potent activity against hepatitis B virus in vitro and in vivo.